Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment. Klement JD, Redd PS, Lu C, Merting AD, et al. Cancer Cell 2023;41:620-636.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Klement JD, Redd PS, Lu C, Merting AD, et al. Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment. Cancer Cell 2023;41:620-636.
PMID: 36917954